Detalhe da pesquisa
1.
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
Ann Oncol
; 31(3): 377-386, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067679
2.
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population.
Ann Oncol
; 30(5): 774-780, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860570
3.
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.
Ann Oncol
; 28(3): 590-596, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993804
4.
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.
Br J Cancer
; 113(1): 30-6, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079300
5.
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.
Br J Cancer
; 110(9): 2195-200, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714751
6.
Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.
Br J Cancer
; 104(2): 272-80, 2011 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21179031
7.
Sequential sorafenib and sunitinib for renal cell carcinoma.
J Urol
; 182(1): 29-34; discussion 34, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447417
8.
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.
Eur J Cancer
; 121: 202-209, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593830
9.
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Eur J Cancer
; 91: 47-55, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331751
10.
[Colorectal cancers: prognostic and predictive factors of response to treatment]. / Les cancers coliques : facteurs pronostiques et prédictifs de la réponse au traitement.
Bull Cancer
; 96(4): 417-23, 2009 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-19357016
11.
[Topics in mTOR pathway and its inhibitors]. / Actualités sur la voie mTOR et ses inhibiteurs.
Bull Cancer
; 96(1): 87-94, 2009 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-19211363